Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)
19.06
+0.04
(+0.21%)
Streaming Delayed Price
Updated: 10:28 AM EST, Dec 31, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 48,678 |
| Open | 18.89 |
| Bid (Size) | 19.05 (300) |
| Ask (Size) | 19.10 (200) |
| Prev. Close | 19.02 |
| Today's Range | 18.89 - 19.30 |
| 52wk Range | 8.180 - 22.50 |
| Shares Outstanding | 47,147,781 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Breaking Down Nurix Therapeutics: 5 Analysts Share Their Views ↗
October 10, 2025
8 Analysts Have This To Say About Nurix Therapeutics ↗
January 29, 2025
What's going on in today's after hours session ↗
July 09, 2025
Frequently Asked Questions
Is Nurix Therapeutics, Inc. - Common stock publicly traded?
Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
What is the current price of Nurix Therapeutics, Inc. - Common stock?
The current price of Nurix Therapeutics, Inc. - Common stock is 19.06
When was Nurix Therapeutics, Inc. - Common stock last traded?
The last trade of Nurix Therapeutics, Inc. - Common stock was at 12/31/25 10:28 AM ET
What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
The market capitalization of Nurix Therapeutics, Inc. - Common stock is 898.64M
How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
Nurix Therapeutics, Inc. - Common stock has 899M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.